Results 91 to 100 of about 535,922 (281)

Distributed Wideband Spectrum Sensing

open access: yes, 2015
6 pages, 6 figures, submitted to ieee Globecom ...
Kealy, Thomas   +2 more
openaire   +2 more sources

Wavelet Transform-Spectrum Sensing

open access: yes, 2022
Spectrum sensing is a vital cognitive radio function that protects licensed users from dangerous interference and finds accessible spectrum for better spectrum use. In practice, however, multipath fading, shadowing, and receiver uncertainty frequently degrade detection performance.
Himanshu, Monga,   +2 more
openaire   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Time Optimal Spectrum Sensing

open access: yes, 2016
Spectrum sensing is a fundamental operation in cognitive radio environment. It gives information about spectrum availability by scanning the bands. Usually a fixed amount of time is given to scan individual bands. Most of the times, historical information about the traffic in the spectrum bands is not used. But this information gives the idea, how busy
Murthy, Garimella Rama   +3 more
openaire   +2 more sources

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Wideband Spectrum Sensing Based on Single-Channel Sub-Nyquist Sampling for Cognitive Radio

open access: yesSensors, 2018
Spectrum sensing is an important task in cognitive radio. However, currently available Analog-to-Digital Converters (ADC) can hardly satisfy the sampling rate requirement for wideband signals. Even with such an ADC, the cost is extremely high in terms of
Changjian Liu   +3 more
doaj   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy